Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Common Stock
Series A Preferred Stock
Common Stock
Series B Preferred Stock
Common Stock
Series C Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series A Preferred Stock
Additional Paid-in Capital
Series B Preferred Stock
Additional Paid-in Capital
Series C Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (48,736) $ 52,809 $ 35,228 $ 65,222 $ 2       $ 10,131       $ (982) $ (211,146)
Beginning balance, shares at Dec. 31, 2020 [1]   21,615,723 8,306,818 12,804,176 17,664,015                  
Exercise of stock options 1,065               1,065          
Exercise of stock options, shares [1]         799,901                  
Stock compensation expense 6,600               6,600          
Issuance of shares to FP Credit Partners. L.P. 22,869       $ 1       22,868          
Issuance of shares to FP Credit Partners. L.P., shares [1]         2,468,492                  
Conversion of warrants to CS 308               308          
Conversion of warrants to CS, shares [1]         672,355                  
Conversion of convertible notes to CS 70,933 $ (52,809) $ (35,228) $ (66,113) $ 4 $ 2 $ 1 $ 1 70,929 $ 52,807 $ 35,227 $ 66,112    
Conversion of convertible notes to CS, shares [1]   (21,615,723) (8,306,818) (12,951,095) 37,034,620 21,615,723 8,306,818 12,951,095            
Issuance of common stock upon the reverse recapitalization, net of issuance costs 206,224       $ 4       206,220          
Issuance of common stock upon the reverse recapitalization, net of issuance costs, shares [1]         44,288,129                  
Contingent earnout liability recognized upon the closing of the reverse recapitalization (58,274)               (58,274)          
Exercise of series C preferred warrants, shares [1]       146,919                    
Exercise of series C preferred warrants 891     $ 891                    
Net loss (102,668)                         (102,668)
Foreign currency translation adjustments 791                       791  
Net unrealized loss on investments (net of tax) 0                          
Ending balance at Sep. 30, 2021 100,003       $ 15       413,993       (191) (313,814)
Ending balance, shares at Sep. 30, 2021 [1]         145,801,148                  
Beginning balance at Jun. 30, 2021 (80,699) $ 52,809 $ 35,228 $ 66,113 $ 2       23,370       (515) (257,706)
Beginning balance, shares at Jun. 30, 2021   21,615,723 8,306,818 12,951,095 19,212,323                  
Exercise of stock options 392               392          
Exercise of stock options, shares         229,316                  
Stock compensation expense 2,099               2,099          
Issuance of shares to FP Credit Partners. L.P. 14,804       $ 1       14,803          
Issuance of shares to FP Credit Partners. L.P., shares         1,490,769                  
Conversion of warrants to CS 308               308          
Conversion of warrants to CS, shares         672,355                  
Conversion of convertible notes to CS 70,933 $ (52,809) $ (35,228) $ (66,113) $ 4 $ 2 $ 1 $ 1 70,929 $ 52,807 $ 35,227 $ 66,112    
Conversion of convertible notes to CS, shares   (21,615,723) (8,306,818) (12,951,095) 37,034,620 21,615,723 8,306,818 12,951,095            
Issuance of common stock upon the reverse recapitalization, net of issuance costs 206,224       $ 4       206,220          
Issuance of common stock upon the reverse recapitalization, net of issuance costs, shares         44,288,129                  
Contingent earnout liability recognized upon the closing of the reverse recapitalization (58,274)               (58,274)          
Net loss (56,108)                         (56,108)
Foreign currency translation adjustments 324                       324  
Net unrealized loss on investments (net of tax) 0                          
Ending balance at Sep. 30, 2021 100,003       $ 15       413,993       (191) (313,814)
Ending balance, shares at Sep. 30, 2021 [1]         145,801,148                  
Beginning balance at Dec. 31, 2021 190,207       $ 15       438,696       732 (249,236)
Beginning balance, shares at Dec. 31, 2021         151,154,614                  
Exercise of stock options $ 797               797          
Exercise of stock options, shares 494,664       494,664                  
Vesting of restricted stock units, shares net of tax withholdings         163,175                  
Vesting of restricted stock units, value net of tax withholdings $ (47)               (47)          
Issuance of common stock upon ESPP purchase 336               336          
Issuance of common stock upon ESPP purchase, shares         257,872                  
Stock compensation expense 8,323               8,323          
Net loss (71,868)                         (71,868)
Foreign currency translation adjustments (5,322)                       (5,322)  
Net unrealized loss on investments (net of tax) (86)                       (86)  
Ending balance at Sep. 30, 2022 122,340       $ 15       448,105       (4,676) (321,104)
Ending balance, shares at Sep. 30, 2022         152,070,325                  
Beginning balance at Jun. 30, 2022 146,023       $ 15       445,005       296 (299,293)
Beginning balance, shares at Jun. 30, 2022         151,929,995                  
Exercise of stock options 1               1          
Vesting of restricted stock units, shares net of tax withholdings         137,830                  
Vesting of restricted stock units, value net of tax withholdings (30)               (30)          
Issuance of common stock upon ESPP purchase 4               4          
Issuance of common stock upon ESPP purchase, shares         2,500                  
Stock compensation expense 3,125               3,125          
Net loss (21,811)                         (21,811)
Foreign currency translation adjustments (4,969)                       (4,969)  
Net unrealized loss on investments (net of tax) (3)                       (3)  
Ending balance at Sep. 30, 2022 $ 122,340       $ 15       $ 448,105       $ (4,676) $ (321,104)
Ending balance, shares at Sep. 30, 2022         152,070,325                  
[1] The shares of the Company’s common and convertible preferred stock prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.7058 established in the Merger.